IRIS
FERRO, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.534
EU - Europa 8.298
AS - Asia 4.029
SA - Sud America 1.453
Continente sconosciuto - Info sul continente non disponibili 186
AF - Africa 138
OC - Oceania 5
Totale 25.643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.346
RU - Federazione Russa 4.368
SG - Singapore 1.652
BR - Brasile 1.257
CN - Cina 1.140
IE - Irlanda 1.012
SE - Svezia 870
HK - Hong Kong 430
IT - Italia 396
UA - Ucraina 395
DE - Germania 335
VN - Vietnam 335
FR - Francia 256
GB - Regno Unito 216
FI - Finlandia 214
IN - India 144
CA - Canada 88
AR - Argentina 79
MX - Messico 59
CZ - Repubblica Ceca 43
IQ - Iraq 41
BD - Bangladesh 40
BE - Belgio 38
TR - Turchia 37
ZA - Sudafrica 37
PL - Polonia 36
EC - Ecuador 31
JP - Giappone 29
MA - Marocco 29
CI - Costa d'Avorio 23
CO - Colombia 22
ES - Italia 22
UZ - Uzbekistan 22
NL - Olanda 21
ID - Indonesia 20
AT - Austria 17
PK - Pakistan 16
VE - Venezuela 14
PY - Paraguay 13
SA - Arabia Saudita 13
EG - Egitto 12
KE - Kenya 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
PE - Perù 9
UY - Uruguay 9
BO - Bolivia 8
JO - Giordania 8
KG - Kirghizistan 8
OM - Oman 8
PH - Filippine 8
DO - Repubblica Dominicana 7
JM - Giamaica 7
NP - Nepal 7
AZ - Azerbaigian 6
CH - Svizzera 6
CR - Costa Rica 6
KR - Corea 6
LV - Lettonia 6
GR - Grecia 5
IR - Iran 5
KZ - Kazakistan 5
LK - Sri Lanka 5
MY - Malesia 5
PA - Panama 5
TN - Tunisia 5
AL - Albania 4
BY - Bielorussia 4
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
MD - Moldavia 4
NO - Norvegia 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
ET - Etiopia 2
GE - Georgia 2
NG - Nigeria 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
Totale 25.442
Salva come PNG Salva come JPEG
Città #
Dallas 5.021
Moscow 1.229
Dublin 1.010
Singapore 850
Ashburn 837
Jacksonville 781
Chandler 726
Nyköping 577
Beijing 449
Hong Kong 429
Council Bluffs 249
The Dalles 232
San Jose 227
Princeton 179
Dearborn 170
Los Angeles 169
Cambridge 167
Medford 160
Lauterbourg 157
Des Moines 134
Ann Arbor 127
Messina 123
Dong Ket 116
Boardman 106
São Paulo 88
Ho Chi Minh City 77
Buffalo 72
New York 64
Lancaster 60
Woodbridge 49
Wilmington 48
Guangzhou 45
Tianjin 45
Orem 44
Hyderabad 41
Jinan 41
San Mateo 40
Pune 38
Redondo Beach 37
Brussels 36
Munich 36
Hanoi 35
Belo Horizonte 34
Santa Clara 34
Shenyang 34
Denver 31
Brasília 30
Brno 30
Brooklyn 30
Frankfurt am Main 30
Catania 29
Rio de Janeiro 29
Nanjing 28
Phoenix 28
Tokyo 25
Johannesburg 24
Montreal 24
Abidjan 23
Houston 23
Turku 23
Lappeenranta 22
Tashkent 22
Warsaw 22
Atlanta 21
Baghdad 21
Chicago 21
Seattle 21
Düsseldorf 20
Haikou 20
Hebei 20
London 19
Porto Alegre 17
Shanghai 17
Hangzhou 16
Goiânia 15
Manchester 15
Milan 15
Ningbo 15
Zhengzhou 15
Chennai 14
Guarulhos 14
Mexico City 14
Mumbai 14
Stockholm 14
Taizhou 14
Vienna 14
Columbus 13
Curitiba 13
Da Nang 13
Guayaquil 13
Ottawa 13
Biên Hòa 12
Boston 12
Campinas 12
Fuzhou 12
Quito 12
San Francisco 12
Contagem 11
Haiphong 11
Poplar 11
Totale 16.252
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.616
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 272
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 259
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 207
AMPA receptor antagonists: Synthesis and pharmacological evaluation 205
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 203
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 191
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 190
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 187
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 187
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 186
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 185
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 184
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 184
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 183
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 182
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 176
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 173
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 172
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 170
Antiretroviral strategy using multi-target agents 166
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 164
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 164
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 164
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 164
Graphene Quantum Dots Based Systems As HIV Inhibitors 163
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 162
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 162
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 162
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 162
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 160
Analysis of Italian regulations on pathways of care for patients in a vegetative or minimally conscious state 160
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 159
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 159
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 158
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 157
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 157
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 155
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 155
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 154
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 152
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 152
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 150
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 148
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 148
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 147
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 145
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 144
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 144
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 142
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 141
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 141
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 140
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 140
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies 140
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 139
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 139
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 138
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 138
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 138
Insight into the INSTIs binding mode: molecular modeling investigation and SAR studies 137
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 137
Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. 137
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 136
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 136
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 136
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 135
Computational studies and synthetic approaches for the identification of new protein-protein interaction inhibitors (PPI) 135
Synthesis, Structure-Activity Relationship Studies, and X-ray Crystallographic Analysis of Arylsulfonamides as Potent Carbonic Anhydrase Inhibitors. 135
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 135
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 134
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 133
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 133
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 132
Identification of potent carbonic anhydrase inhibitors: synthesis, biological evaluation and enzyme-ligand x-ray studies 132
Design, Synthesis and Biostructural Characterization of Carbonic Anhydrase Inhibitors 131
Rational design, synthesis and evaluation of coumarin derivatives as protein-protein interaction inhibitors 131
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 130
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 130
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 129
New potent and selective carbonic anhydrase inhibitors: synthesis, biological evaluation and X-ray studies 129
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 128
Synthesis and biological characterization of novel potent arylsulfonamides as human carbonic anhydrase inhibitors (hCAIs) targeting central nervous system 128
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 127
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors 127
Synthesis of new potential HIV-1 integrase inhibitors 126
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: Synthesis, biological evaluation, and molecular modeling studies 126
Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase inhibitors 125
Identification of 3-substituted-1H-indoles as ligands of GluN2B containing N-methyl-D-aspartate receptors 125
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 124
Microwave assisted organic synthesis (MAOS) of small molecules as potential HIV-1 integrase inhibitors. 124
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 123
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 122
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 120
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 117
Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening 114
N-Substituted Isoquinoline Derivatives as Potential AChE Inhibitors 114
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 112
ISOQUINOLINE-SULFONAMIDES AS A CLASS OF POTENT AND SELECTIVE CARBONIC ANHYDRASE INHIBITORS 112
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 109
Totale 19.491
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.486
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.050 0 161 25 48 38 11 81 39 28 11 258 350
2022/20232.901 242 254 143 218 212 297 54 148 1.232 8 74 19
2023/2024682 57 102 50 134 56 124 7 16 1 56 14 65
2024/20253.163 59 46 59 181 109 123 53 728 804 185 277 539
2025/202613.954 363 1.970 3.725 886 780 2.210 1.070 1.224 1.145 336 123 122
2026/2027366 139 227 0 0 0 0 0 0 0 0 0 0
Totale 25.643